ask="N/A"
ask_size="N/A"
average_daily_volume="31167"
bid="3.12"
bid_size="100"
book_value="3.34"
change="+0.10"
change_from_200_day_moving_average="4.82"
change_from_50_day_moving_average="2.33"
change_from_52_week_high="-0.95"
change_From_52_week_low="8.28"
change_in_percent="+0.85%"
close="11.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.53"
eps_estimate_next_quarter="-0.60"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="11.99"
high_52_weeks="12.75"
last_trade_date="3/7/2017"
last_trade_price="11.80"
last_trade_size="100"
last_trade_time="3:59pm"
low="11.31"
low_52_weeks="3.52"
market_capitalization="251.10M"
moving_average_200_day="6.98"
moving_average_50_day="9.47"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="15.81"
open="11.58"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+68.96%"
percent_change_from_50_day_moving_average="+24.64%"
percent_change_from_52_week_high="-7.45%"
percent_change_from_52_week_low="+235.23%"
previous_close="11.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.50"
price_per_sales="47.88"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.35"
stock_exchange="NMS"
symbol="NBRV"
volume="26838"
weeks_range_52="3.52 - 12.75"
